Evidence map›Paper›PMID 41010278›Full record

ArticleLife (Basel, Switzerland)2025

Triple Pulmonary Coinfection with SARS-CoV-2,

Wei-Hung Chang, Ting-Yu Hu, Li-Kuo Kuo

Abstract readCase Reports
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wei-Hung ChangDepartment of Critical Care Medicine, MacKay Memorial Hospital, Taipei 10449, Taiwan.ORCID 0009-0000-8179-0486
Ting-Yu HuDepartment of Critical Care Medicine, MacKay Memorial Hospital, Taipei 10449, Taiwan.ORCID 0000-0002-8251-3808
Li-Kuo KuoDepartment of Critical Care Medicine, MacKay Memorial Hospital, Taipei 10449, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary coinfection involving both viral and opportunistic pathogens is an emerging challenge in immunosuppressed patients. We report the case of a 59-year-old man with rheumatoid arthritis on long-term immunosuppressive therapy who developed necrotizing pneumonia and acute respiratory failure and was ultimately diagnosed with triple pulmonary coinfection by SARS-CoV-2,

Indexed as

Aspergillus fumigatusCOVID-19ICUimmunosuppressionnecrotizing pneumoniaNocardia cyriacigeorgicarheumatoid arthritisSARS-CoV-2triple infection

Identifiers

PMID41010278
PMCPMC12470667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.